From Innovation to Scalable Manufacturing: Closing the Gap

About this session

How can breakthrough innovation become scalable, GMP-ready biomanufacturing? Bringing together biotech, translational research and CDMO perspectives across emerging therapeutic technologies, this panel explores the challenges of process development, scale-up and industrialisation - and the partnerships needed to transform scientific advances into robust, manufacturable and commercially viable products.

Speakers

• DH

  David Honba

  COO · BioWin, Health Innovation Cluster of Wallonia

  Moderator

• NR

  Nicolas Rousseau

  COO · EVerZom

  Speaker

• VB

  Vincent Bischoff

  COO · Superbranche

  Speaker

• JC

  Jason Conner

  CEO · Cellistic

  Speaker

• TS

  Thomas Schmid

  Head of GMP Biopharmaceuticals · Fraunhofer IZI

  Speaker